ARKG vs VO
ARK Genomic Revolution ETF vs Vanguard Mid-Cap ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
VO—
Vanguard Mid-Cap ETF
US mid-cap stocks across sectors.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | VO |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Vanguard |
ARKG top holdings
Holdings data unavailable for ARKG.
VO top holdings
Holdings data unavailable for VO.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About VO
VO (Vanguard Mid-Cap ETF) is US mid-cap stocks across sectors.